Job Rocha awarded BioLegend Graduate Fellowship in Immunology
Rocha aims to understand a devastating liver disease
Research Center Center for Sex-based Differences in the Immune System
Weiskopf Lab
The Weiskopf is devoted to understanding T cell responses in emerging infectious viruses relevant to human health and disease.
Vijayanand Lab
Pandurangan Vijayanand, M.D., Ph.D., and his lab members employ genomics tools to understand, diagnose and treat pulmonary disease such as asthma, lung cancer and infectious diseases, including the novel coronavirus.
Shresta Lab
Sujan Shresta, Ph.D., and her team study the immunology and virology of mosquito-borne human pathogens such as dengue virus and Zika virus.
Sharma Lab
Sonia Sharma, Ph.D., and her lab members lead unbiased, genome-scale approaches to unravel innate immunity, the body’s early immune response to microbial pathogens and neoplastic cells.
Schmiedel Lab
Dr. Schmiedel is dedicated to shedding light on the genetic mechanisms driving the pathogenesis of human diseases. His research is revealing molecular features regulating immune cell function to enhance our understanding and advance disease diagnosis, treatment, and prevention.
Saphire Lab
Erica Ollmann Saphire, Ph.D., MBA, studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
Rao Lab
Anjana Rao, Ph.D., focuses on understanding how signaling pathways control gene expression, using T cells and other cells of the immune system as models.
Myers Lab
Samuel Myers, Ph.D., studies the signaling circuits that drive the behavior of individual immune cells and ultimately orchestrate systemic immune responses.
Crotty Lab
Shane Crotty, Ph.D., and his team study immunity against infectious diseases. They investigate how the immune system remembers infections and vaccines.
LJI selected as member of ARPA-H Investor Catalyst Hub Spoke Network
LJI joins a nationwide network working to accelerate transformative health solutions
Zika
LJI scientists are investigating new strategies for stopping Zika virus.
Type 1 Diabetes
Type 1 diabetes accounts for up to 2 million U.S. cases and occurs when the immune system mistakenly destroys insulin-producing cells in the pancreas.
Seasonal Allergies
Millions of people suffer from seasonal allergies. For them, the onset of spring signals several months of misery.
Parkinson’s Disease
Researchers at La Jolla Institute are investigating how the immune system may contribute to Parkinson's disease.
Lassa Fever
Lassa virus is endemic to West Africa and kills nearly 5,000 people a year. Research led by La Jolla Institute scientists lays the groundwork for anti-Lassa vaccine development.
Inflammatory bowel disease
Researchers at La Jolla Institute are working to prevent the symptoms of IBD before inflammation escalates.
COVID-19
Scientists in the La Jolla Institute for Immunology (LJI) remain at the forefront of research into COVID-19 vaccines, therapies, and the disease's long-term effects.
CMV
CMV is the number one infectious cause of congenital birth defects worldwide. Researchers at La Jolla Institute are working to define the molecular underpinnings of CMV infection.
Autoimmune Disease
Scientists at La Jolla Institute are investigating what causes immune cells to turn on the body—and how we can intervene.
Atopic Dermatitis / Eczema
Atopic dermatitis occurs when a person’s immune system causes inflammation of the skin, which also makes the skin more vulnerable to environmental irritants and allergens.
Heart Disease
Heart disease, also called cardiovascular disease, can describe several conditions, including coronary artery disease and aortic athlerosclerosis.
Asthma
Asthma affects more than 25 million people across the nation—7 million of them children—and the incidence is rising.
Alzheimer’s disease
La Jolla Institute scientists are working to understand how the body's T cells may target the proteins involved in the plaques and tangles seen in brains with Alzheimer's disease.
Reina Lab
Dr. Reina-Campos’ lab seeks to understand the underlying principles governing tissue immune networks that enable robust and long-term protection against infection and tumors.
Daniela Weiskopf appointed LJI Assistant Professor
The Weiskopf lab studies how the body battles emerging viruses to prepare for pandemic threats
Ay Lab
Ferhat Ay, Ph.D., works to understand gene regulation in complex organisms and diseases.
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
LJI home to new “Center of Excellence”
LJI's Flow Cytometry Core brings cutting-edge technology to immune system researchers
Ken and Barbara Magid inspire generational giving
“Barbara and I are not going to be here forever, so I wanted to get our kids involved"
LJI advocates for more research into immune system differences between men and women
Institute President and CEO Erica Ollmann Saphire, Ph.D., joins national leaders in highlighting the importance of studying sex-based immune system differences
Research and legal expert Emily Holmes to join LJI Board of Directors
Holmes has led the charge in intellectual property and regulatory compliance at two renowned biomedical centers
LJI team uncovers new subsets of CD4+ ‘helper’ T cells
New analysis shows men and women really do have immune cell differences
WHAM and La Jolla Institute for Immunology identify economic imperative of research focused on women, partner to accelerate autoimmune research focused on women
New study shows autoimmune rheumatoid arthritis research focused on women will bring billions to the economy. Leading immune research institute announces new sex and gender focus.
In Autoimmune Disease, Organs May Lure the Immune System into an Attack
New evidence indicates that target cells may play a role in their own destruction.
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
